Provepharm Life Solutions is an independent French pharmaceutical company. Since its creation in 1998, the company has leveraged its expertise in fine chemistry and is a pioneer in the 'third way', based on the vitalization of mature and known molecules. The first products developed were based on methylene blue and are distributed in over 30 countries around the world. Provepharm Life Solutions' strategy consists of developing its range of products, applying its expertise for the vitalization of other molecules and strengthening its international business. Based in Marseille (France) and in Philadelphia (USA), Provepharm Life Solutions employs over 100 staff. The company recorded a turnover of €37.5 million ($44M) in 2019. It also raised €42.5 ($49.8M) million in capital at the beginning of 2019, one of the largest syndicated loans in the region.